L

LPTX

Leap Therapeutic

0.41

0.01+2.25%
After Hours: 0.3901  -0.02  -4.62%19:37 05/14 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

49.12M

72.83M

70.35M

117.91M

54.37M

Total Current Assets

48.04M

71.60M

67.95M

116.87M

52.27M

Total Non Current Assets

1.08M

1.23M

2.40M

1.04M

2.10M

Total Liabilities

14.08M

12.68M

11.49M

10.02M

7.72M

Total Current Liabilities

14.08M

12.68M

11.22M

9.99M

7.37M

Total Non Current Liabilities

0

0

262.00K

37.00K

348.00K

Total Equity

35.05M

60.14M

58.87M

107.89M

46.65M

Total Stockholders Equity

35.05M

60.14M

58.87M

107.89M

46.65M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

49.12M

72.83M

70.35M

117.91M

54.37M

Total Common Shares Outstanding

38.33M

25.57M

9.90M

8.83M

5.97M

Total Preferred Shares Outstanding

--

--

--

--

--